Alnylam Pharmaceuticals, Inc. (ALNY)
Biotechnology · Healthcare · $37.8B
Intrinsic Value (Consensus)
$28.97
Current Price
$282.85
Margin of Safety
-89.8%
89.8% Above Intrinsic Value
Value: $29
Price: $283
Valuation Model Estimates
Current Price: $282.85
DCF (Discounted Cash Flow)
$164.86
Graham Number
$17.68
Earnings Power Value
$22.62
Relative Value (P/E)
$46.60
Dividend Discount Model
Not applicable
—
Consensus Value
$28.97
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $2.33
- EPS (Forward)
- $2.80
- Book Value
- $5.96
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 39.8%
- Debt/Equity
- 86%
- Revenue Growth
- 65.2%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 0.27
Data last updated: 2026-06-12
Source: Yahoo Finance